An updated view on stem cell differentiation into smooth muscle cells

Vascular Pharmacology

Volumn 56, Issue 5-6, 2012, Pages 280-287

  Zhang, Li ^a   Zhou, Yijiang ^a   Zhu, Jianhua ^a   Xu, Qingbo ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Chromatin; HDAC; ROS; Smooth muscle cells; Stem cells

Indexed keywords

MICRORNA; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR;

CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CHROMATIN; EPIGENETICS; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; STEM CELL; STEM CELL TRANSPLANTATION; ANIMAL; BLOOD VESSEL; GENE EXPRESSION REGULATION; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; TISSUE ENGINEERING;

ANIMALS; BLOOD VESSELS; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MYOCYTES, SMOOTH MUSCLE; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING;

EID: 84866165383     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2012.02.014     Document Type: Review

References (97)

1. Adams B., Xiao Q., Xu Q. Stem cell therapy for vascular disease. Trends Cardiovasc. Med. 2007, 17:246-251.
2. Albinsson S., Suarez Y., Skoura A., Offermanns S., Miano J.M., Sessa W.C. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1118-1126.
3. Berezikov E., Guryev V., van de Belt J., Wienholds E., Plasterk R.H., Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005, 120:21-24.
4. Boettger T., Beetz N., Kostin S., Schneider J., Kruger M., Hein L., Braun T. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J. Clin. Invest. 2009, 119:2634-2647.
5. Borradaile N.M., Pickering J.G. NAD(+), sirtuins, and cardiovascular disease. Curr. Pharm. Des. 2009, 15:110-117.
6. Boucher J.M., Peterson S.M., Urs S., Zhang C., Liaw L. The miR-143/145 cluster is a novel transcriptional target of jagged-1/Notch signaling in vascular smooth muscle cells. J. Biol. Chem. 2011, 286:28312-28321.
7. Bouvard D., Brakebusch C., Gustafsson E., Aszodi A., Bengtsson T., Berna A., Fassler R. Functional consequences of integrin gene mutations in mice. Circ. Res. 2001, 89:211-223.
8. Brons I.G., Smithers L.E., Trotter M.W., Rugg-Gunn P., Sun B., de Sousa Chuva, Lopes S.M., Howlett S.K., Clarkson A., Ahrlund-Richter L., Pedersen R.A., Vallier L. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 2007, 448:191-195.
9. Brown J.P., Bullwinkel J., Baron-Luhr B., Billur M., Schneider P., Winking H., Singh P.B. HP1gamma function is required for male germ cell survival and spermatogenesis. Epigenetics Chromatin 2010, 3:9.
10. Brunelli S., Cossu G. A role for MSX2 and necdin in smooth muscle differentiation of mesoangioblasts and other mesoderm progenitor cells. Trends Cardiovasc. Med. 2005, 15:96-100.
11. Brunelli S., Tagliafico E., De Angelis F.G., Tonlorenzi R., Baesso S., Ferrari S., Niinobe M., Yoshikawa K., Schwartz R.J., Bozzoni I., Cossu G. Msx2 and necdin combined activities are required for smooth muscle differentiation in mesoangioblast stem cells. Circ. Res. 2004, 94:1571-1578.
12. Cammas F., Oulad-Abdelghani M., Vonesch J.L., Huss-Garcia Y., Chambon P., Losson R. Cell differentiation induces TIF1beta association with centromeric heterochromatin via an HP1 interaction. J. Cell Sci. 2002, 115:3439-3448.
13. Cammas F., Herzog M., Lerouge T., Chambon P., Losson R. Association of the transcriptional corepressor TIF1beta with heterochromatin protein 1 (HP1): an essential role for progression through differentiation. Genes Dev. 2004, 18:2147-2160.
14. Cammas F., Janoshazi A., Lerouge T., Losson R. Dynamic and selective interactions of the transcriptional corepressor TIF1 beta with the heterochromatin protein HP1 isotypes during cell differentiation. Differentiation 2007, 75:627-637.
15. Cao D., Wang Z., Zhang C.L., Oh J., Xing W., Li S., Richardson J.A., Wang D.Z., Olson E.N. Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin. Mol. Cell. Biol. 2005, 25:364-376.
16. Carvajal J.J., Cox D., Summerbell D., Rigby P.W. A BAC transgenic analysis of the Mrf4/Myf5 locus reveals interdigitated elements that control activation and maintenance of gene expression during muscle development. Development 2001, 128:1857-1868.
17. Cave A.C., Brewer A.C., Narayanapanicker A., Ray R., Grieve D.J., Walker S., Shah A.M. NADPH oxidases in cardiovascular health and disease. Antioxid. Redox Signal. 2006, 8:691-728.
18. Chen J.F., Mandel E.M., Thomson J.M., Wu Q., Callis T.E., Hammond S.M., Conlon F.L., Wang D.Z. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 2006, 38:228-233.
19. Chen J., Yin H., Jiang Y., Radhakrishnan S.K., Huang Z.P., Li J., Shi Z., Kilsdonk E.P., Gui Y., Wang D.Z., Zheng X.L. Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation. Arterioscler. Thromb. Vasc. Biol. 2011, 31:368-375.
20. Cheng Y., Liu X., Yang J., Lin Y., Xu D.Z., Lu Q., Deitch E.A., Huo Y., Delphin E.S., Zhang C. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ. Res. 2009, 105:158-166.
21. Cheung C., Sinha S. Human embryonic stem cell-derived vascular smooth muscle cells in therapeutic neovascularisation. J. Mol. Cell. Cardiol. 2011, 51:651-664.
22. Chowdhury I., Mo Y., Gao L., Kazi A., Fisher A.B., Feinstein S.I. Oxidant stress stimulates expression of the human peroxiredoxin 6 gene by a transcriptional mechanism involving an antioxidant response element. Free Radic. Biol. Med. 2009, 46:146-153.
23. Clempus R.E., Griendling K.K. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc. Res. 2006, 71:216-225.
24. Clempus R.E., Sorescu D., Dikalova A.E., Pounkova L., Jo P., Sorescu G.P., Schmidt H.H., Lassegue B., Griendling K.K. Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 2007, 27:42-48.
25. Condorelli G., Latronico M.V., Dorn G.W. MicroRNAs in heart disease: putative novel therapeutic targets?. Eur. Heart J. 2010, 31:649-658.
26. Cordes K.R., Sheehy N.T., White M.P., Berry E.C., Morton S.U., Muth A.N., Lee T.H., Miano J.M., Ivey K.N., Srivastava D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
27. Elia L., Quintavalle M., Zhang J., Contu R., Cossu L., Latronico M.V., Peterson K.L., Indolfi C., Catalucci D., Chen J., Courtneidge S.A., Condorelli G. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ. 2009, 16:1590-1598.
28. Etchevers H.C. The cap 'n' collar family member NF-E2-related factor 3 (Nrf3) is expressed in mesodermal derivatives of the avian embryo. Int. J. Dev. Biol. 2005, 49:363-367.
29. Fisher S.A. Vascular smooth muscle phenotypic diversity and function. Physiol. Genomics 2010, 42A:169-187.
30. Gore A., Li Z., Fung H.L., Young J.E., Agarwal S., Antosiewicz-Bourget J., Canto I., Giorgetti A., Israel M.A., Kiskinis E., Lee J.H., Loh Y.H., Manos P.D., Montserrat N., Panopoulos A.D., Ruiz S., Wilbert M.L., Yu J., Kirkness E.F., Izpisua Belmonte J.C., Rossi D.J., Thomson J.A., Eggan K., Daley G.Q., Goldstein L.S., Zhang K. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011, 471:63-67.
31. Gray S.G., Ekstrom T.J. The human histone deacetylase family. Exp. Cell Res. 2001, 262:75-83.
32. Guo H., Ingolia N.T., Weissman J.S., Bartel D.P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466:835-840.
33. Han A., He J., Wu Y., Liu J.O., Chen L. Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2. J. Mol. Biol. 2005, 345:91-102.
34. He Y., Smith R. Nuclear functions of heterogeneous nuclear ribonucleoproteins A/B. Cell. Mol. Life Sci. 2009, 66:1239-1256.
35. Hiltunen M.O., Turunen M.P., Hakkinen T.P., Rutanen J., Hedman M., Makinen K., Turunen A.M., Aalto-Setala K., Yla-Herttuala S. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc. Med. 2002, 7:5-11.
36. Hsu C.P., Odewale I., Alcendor R.R., Sadoshima J. Sirt1 protects the heart from aging and stress. Biol. Chem. 2008, 389:221-231.
37. Huang H., Xie C., Sun X., Ritchie R.P., Zhang J., Chen Y.E. miR-10a contributes to retinoid acid-induced smooth muscle cell differentiation. J. Biol. Chem. 2010, 285:9383-9389.
38. Ivey K.N., Srivastava D. MicroRNAs as regulators of differentiation and cell fate decisions. Cell Stem Cell 2010, 7:36-41.
39. Kane N.M., Xiao Q., Baker A.H., Luo Z., Xu Q., Emanueli C. Pluripotent stem cell differentiation into vascular cells: a novel technology with promises for vascular re(generation). Pharmacol. Ther. 2011, 129:29-49.
40. Li T., Cao H., Zhuang J., Wan J., Guan M., Yu B., Li X., Zhang W. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin. Chim. Acta 2011, 412:66-70.
41. Li X., Chu J., Wang A., Zhu Y., Chu W.K., Yang L., Li S. Uniaxial mechanical strain modulates the differentiation of neural crest stem cells into smooth muscle lineage on micropatterned surfaces. PLoS One 2011, 6:e26029.
42. Liu G.H., Barkho B.Z., Ruiz S., Diep D., Qu J., Yang S.L., Panopoulos A.D., Suzuki K., Kurian L., Walsh C., Thompson J., Boue S., Fung H.L., Sancho-Martinez I., Zhang K., Yates J., Izpisua Belmonte J.C. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 2011, 472:221-225.
43. Long X., Miano J.M. Transforming growth factor-{beta}1 (TGF-{beta}1) utilizes distinct pathways for the transcriptional activation of microRNA 143/145 in human coronary artery smooth muscle cells. J. Biol. Chem. 2011, 286:30119-30129.
44. Manabe I., Owens G.K. Recruitment of serum response factor and hyperacetylation of histones at smooth muscle-specific regulatory regions during differentiation of a novel P19-derived in vitro smooth muscle differentiation system. Circ. Res. 2001, 88:1127-1134.
45. Margariti A., Xiao Q., Zampetaki A., Zhang Z., Li H., Martin D., Hu Y., Zeng L., Xu Q. Splicing of HDAC7 modulates the SRF-myocardin complex during stem-cell differentiation towards smooth muscle cells. J. Cell Sci. 2009, 122:460-470.
46. Marmorstein R. Protein modules that manipulate histone tails for chromatin regulation. Nat. Rev. Mol. Cell Biol. 2001, 2:422-432.
47. Martinez N.J., Gregory R.I. MicroRNA gene regulatory pathways in the establishment and maintenance of ESC identity. Cell Stem Cell 2010, 7:31-35.
48. Mayshar Y., Ben-David U., Lavon N., Biancotti J.C., Yakir B., Clark A.T., Plath K., Lowry W.E., Benvenisty N. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010, 7:521-531.
49. McDonald O.G., Owens G.K. Programming smooth muscle plasticity with chromatin dynamics. Circ. Res. 2007, 100:1428-1441.
50. Meseguer S., Mudduluru G., Escamilla J.M., Allgayer H., Barettino D. MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF). J. Biol. Chem. 2011, 286:4150-4164.
51. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 1995, 75:487-517.
52. Owens G.K. Molecular control of vascular smooth muscle cell differentiation and phenotypic plasticity. Novartis Found. Symp. 2007, 283:174-191. discussion 191-173, 238-141.
53. Owens G.K., Kumar M.S., Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 2004, 84:767-801.
54. Pan Y., Balazs L., Tigyi G., Yue J. Conditional deletion of Dicer in vascular smooth muscle cells leads to the developmental delay and embryonic mortality. Biochem. Biophys. Res. Commun. 2011, 408:369-374.
55. Parmacek M.S. Myocardin - not quite MyoD. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1535-1537.
56. Pepe A.E., Xiao Q., Zampetaki A., Zhang Z., Kobayashi A., Hu Y., Xu Q. Crucial role of nrf3 in smooth muscle cell differentiation from stem cells. Circ. Res. 2010, 106:870-879.
57. Poschl E., Schlotzer-Schrehardt U., Brachvogel B., Saito K., Ninomiya Y., Mayer U. Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development 2004, 131:1619-1628.
58. Rangrez A.Y., Massy Z.A., Metzinger-Le Meuth V., Metzinger L. miR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells. Circ. Cardiovasc. Genet. 2011, 4:197-205.
59. Sankaranarayanan K., Jaiswal A.K. Nrf3 negatively regulates antioxidant-response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. J. Biol. Chem. 2004, 279:50810-50817.
60. Sone M., Itoh H., Yamashita J., Yurugi-Kobayashi T., Suzuki Y., Kondo Y., Nonoguchi A., Sawada N., Yamahara K., Miyashita K., Park K., Shibuya M., Nito S., Nishikawa S., Nakao K. Different differentiation kinetics of vascular progenitor cells in primate and mouse embryonic stem cells. Circulation 2003, 107:2085-2088.
61. Sone M., Itoh H., Yamahara K., Yamashita J.K., Yurugi-Kobayashi T., Nonoguchi A., Suzuki Y., Chao T.H., Sawada N., Fukunaga Y., Miyashita K., Park K., Oyamada N., Taura D., Tamura N., Kondo Y., Nito S., Suemori H., Nakatsuji N., Nishikawa S., Nakao K. Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arterioscler. Thromb. Vasc. Biol. 2007, 27:2127-2134.
62. Sorescu D., Weiss D., Lassegue B., Clempus R.E., Szocs K., Sorescu G.P., Valppu L., Quinn M.T., Lambeth J.D., Vega J.D., Taylor W.R., Griendling K.K. Superoxide production and expression of Nox family proteins in human atherosclerosis. Circulation 2002, 105:1429-1435.
63. Spin J.M., Quertermous T., Tsao P.S. Chromatin remodeling pathways in smooth muscle cell differentiation, and evidence for an integral role for p300. PLoS One 2010, 5:e14301.
64. Staus D.P., Blaker A.L., Taylor J.M., Mack C.P. Diaphanous 1 and 2 regulate smooth muscle cell differentiation by activating the myocardin-related transcription factors. Arterioscler. Thromb. Vasc. Biol. 2007, 27:478-486.
65. Sterner D.E., Berger S.L. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 2000, 64:435-459.
66. Su B., Mitra S., Gregg H., Flavahan S., Chotani M.A., Clark K.R., Goldschmidt-Clermont P.J., Flavahan N.A. Redox regulation of vascular smooth muscle cell differentiation. Circ. Res. 2001, 89:39-46.
67. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
68. Takanashi M., Oikawa K., Fujita K., Kudo M., Kinoshita M., Kuroda M. Heterochromatin protein 1gamma epigenetically regulates cell differentiation and exhibits potential as a therapeutic target for various types of cancers. Am. J. Pathol. 2009, 174:309-316.
69. Tesar P.J., Chenoweth J.G., Brook F.A., Davies T.J., Evans E.P., Mack D.L., Gardner R.L., McKay R.D. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007, 448:196-199.
70. Turunen M.P., Aavik E., Yla-Herttuala S. Epigenetics and atherosclerosis. Biochim. Biophys. Acta 2009, 1790:886-891.
71. Wada H., Hasegawa K., Morimoto T., Kakita T., Yanazume T., Sasayama S. A p300 protein as a coactivator of GATA-6 in the transcription of the smooth muscle-myosin heavy chain gene. J. Biol. Chem. 2000, 275:25330-25335.
72. Waltregny D., De Leval L., Glenisson W., Ly Tran S., North B.J., Bellahcene A., Weidle U., Verdin E., Castronovo V. Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues. Am. J. Pathol. 2004, 165:553-564.
73. Waltregny D., Glenisson W., Tran S.L., North B.J., Verdin E., Colige A., Castronovo V. Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility. FASEB J. 2005, 19:966-968.
74. Wang Z., Wang D.Z., Hockemeyer D., McAnally J., Nordheim A., Olson E.N. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 2004, 428:185-189.
75. Wang G., Xiao Q., Luo Z., Ye S., Xu Q. Functional impact of heterogeneous nuclear ribonucleoprotein a2/b1 in smooth muscle differentiation from stem cells and embryonic arteriogenesis. J. Biol. Chem. 2012, 287:2896-2906.
76. Wollert K.C., Drexler H. Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat. Rev. Cardiol. 2010, 7:204-215.
77. Wu X.M., Liu M.Y., Ge X.X., Xu Q., Guo W.W. Stage and tissue-specific modulation of ten conserved miRNAs and their targets during somatic embryogenesis of Valencia sweet orange. Planta 2011, 233:495-505.
78. Xiao Q., Zeng L., Zhang Z., Margariti A., Ali Z.A., Channon K.M., Xu Q., Hu Y. Sca-1+ progenitors derived from embryonic stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Arterioscler. Thromb. Vasc. Biol. 2006, 26:2244-2251.
79. Xiao Q., Zeng L., Zhang Z., Hu Y., Xu Q. Stem cell-derived Sca-1+ progenitors differentiate into smooth muscle cells, which is mediated by collagen IV-integrin {alpha}1/beta1/{alpha}v and PDGF receptor pathways. Am. J. Physiol. Cell Physiol. 2007, 292:C342-C352.
80. 2. Am. J. Physiol. Cell Physiol. 2009, 296:C711-C723.
81. Xiao Q., Wang G., Luo Z., Xu Q. The mechanism of stem cell differentiation into smooth muscle cells. Thromb. Haemost. 2010, 104:440-448.
82. Xiao Q., Wang G., Yin X., Luo Z., Margariti A., Zeng L., Mayr M., Ye S., Xu Q. Chromobox protein homolog 3 is essential for stem cell differentiation to smooth muscles in vitro and in embryonic arteriogenesis. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1842-1852.
83. Xin M., Small E.M., Sutherland L.B., Qi X., McAnally J., Plato C.F., Richardson J.A., Bassel-Duby R., Olson E.N. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 2009, 23:2166-2178.
84. Xu Q. Stem cells and transplant arteriosclerosis. Circ. Res. 2008, 102:1011-1024.
85. Xu N., Papagiannakopoulos T., Pan G., Thomson J.A., Kosik K.S. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 2009, 137:647-658.
86. Yamaguchi S., Yamahara K., Homma K., Suzuki S., Fujii S., Morizane R., Monkawa T., Matsuzaki Y., Kangawa K., Itoh H. The role of microRNA-145 in human embryonic stem cell differentiation into vascular cells. Atherosclerosis 2011, 219:468-474.
87. Yamahara K., Sone M., Itoh H., Yamashita J.K., Yurugi-Kobayashi T., Homma K., Chao T.H., Miyashita K., Park K., Oyamada N., Sawada N., Taura D., Fukunaga Y., Tamura N., Nakao K. Augmentation of neovascularization [corrected] in hindlimb ischemia by combined transplantation of human embryonic stem cells-derived endothelial and mural cells. PLoS One 2008, 3:e1666.
88. Yamashita J., Itoh H., Hirashima M., Ogawa M., Nishikawa S., Yurugi T., Naito M., Nakao K. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000, 408:92-96.
89. Yin X., Mayr M., Xiao Q., Wang W., Xu Q. Proteomic analysis reveals higher demand for antioxidant protection in embryonic stem cell-derived smooth muscle cells. Proteomics 2006, 6:6437-6446.
90. Yoshida T., Kawai-Kowase K., Owens G.K. Forced expression of myocardin is not sufficient for induction of smooth muscle differentiation in multipotential embryonic cells. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1596-1601.
91. Yoshida T., Gan Q., Owens G.K. Kruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids. Am. J. Physiol. Cell Physiol. 2008, 295:C1175-C1182.
92. Zhang Y., Kobayashi A., Yamamoto M., Hayes J.D. The Nrf3 transcription factor is a membrane-bound glycoprotein targeted to the endoplasmic reticulum through its N-terminal homology box 1 sequence. J. Biol. Chem. 2009, 284:3195-3210.
93. Zhao Y., Samal E., Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005, 436:214-220.
94. Zhao T., Zhang Z.N., Rong Z., Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 2011, 474:212-215.
95. Zhou B., Margariti A., Zeng L., Habi O., Xiao Q., Martin D., Wang G., Hu Y., Wang X., Xu Q. Splicing of histone deacetylase 7 modulates smooth muscle cell proliferation and neointima formation through nuclear beta-catenin translocation. Arterioscler. Thromb. Vasc. Biol. 2011, 31:2676-2684.
96. Zhou B., Margariti A., Zeng L., Xu Q. Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis. Cardiovasc. Res. 2011, 90:413-420.
97. Zhu H., Lensch M.W., Cahan P., Daley G.Q. Investigating monogenic and complex diseases with pluripotent stem cells. Nat. Rev. Genet. 2011, 12:266-275.